Table 4.
Non-Recovered Potential DCDs (n = 245) | Actual DCDs (n = 245) | Standardized Difference | |
---|---|---|---|
| |||
Age | 48.0 (34.0–55.0) | 46.0 (37.0–54.0) | −0.02 |
Male Gender | 179 (73.1%) | 181 (73.9%) | −0.02 |
Height | 175.3 (168.0–182.0) | 175.0 (168.0–182.9) | −0.05 |
Weight | 81.2 (71.1–95.0) | 80.7 (70.7–92.3) | −0.05 |
BMI | 26.9 (23.6–31.0) | 26.3 (23.5–30.7) | −0.05 |
AST | 43.0 (28.0–58.0) | 36.0 (25.0–51.0) | 0.07 |
ALT | 33.0 (20.0–46.0) | 28.0 (18.0–40.0) | 0.09 |
Total Bilirubin | 0.5 (0.3–0.7) | 0.5 (0.3–0.7) | 0.03 |
Diabetes | 26 (10.6%) | 27 (11.0%) | −0.01 |
Ethinicity | |||
Caucasian | 203 (82.9%) | 197 (80.4%) | 0.06 |
African American | 16 (6.5%) | 17 (6.9%) | −0.02 |
Hispanic | 20 (8.2%) | 22 (9.0%) | −0.03 |
Asian | 2 (0.8%) | 2 (0.8%) | 0.00 |
Native American/Other | 4 (1.6%) | 7 (2.9%) | −0.08 |
ABO | |||
A | 92 (37.6%) | 98 (40.0%) | −0.05 |
AB | 10 (4.1%) | 8 (3.3%) | 0.04 |
B | 37 (15.1%) | 36 (14.7%) | 0.01 |
O | 106 (43.3%) | 103 (42.0%) | 0.02 |
Cause of Death | |||
Anoxia | 115 (46.9%) | 116 (47.4%) | −0.01 |
CVA | 51 (20.8%) | 55 (22.5%) | −0.04 |
Trauma | 63 (25.7%) | 56 (22.9%) | 0.07 |
Other | 16 (6.5%) | 18 (7.4%) | −0.03 |
IV Drug Use | 45 (18.4%) | 41 (16.7%) | 0.04 |
Withdrawal to Crossclamp Interval (minutes) | 24.0 (20.0–27.0) | 23.0 (19.0–27.0) | −0.03 |
HIV NAT | |||
Negative | 236 (96.3%) | 234 (95.5%) | 0.04 |
Not Done | 2 (0.8%) | 1 (0.4%) | 0.05 |
Prior to Routine Collection | 7 (2.9%) | 10 (4.1%) | −0.07 |
Hepatitis C NAT | |||
Positive | 21 (8.6%) | 17 (6.9%) | 0.06 |
Negative | 217 (88.6%) | 218 (89.0%) | −0.01 |
Prior to Routine Collection | 7 (2.9%) | 10 (4.1%) | −0.07 |
Hepatitis C Serology Positive | 32 (13.1%) | 24 (9.8%) | 0.10 |
Heavy Alcohol Use | |||
Yes | 76 (31.0%) | 73 (29.8%) | 0.03 |
No | 163 (66.5%) | 165 (67.4%) | −0.02 |
Unknown | 6 (2.5%) | 7 (2.9%) | −0.03 |